<div id="readability-page-1"><div><div>Famed short-seller Andrew Left of Citron Research is taking a victory lap on a bullish call, celebrating his firm’s early bet on AI infrastructure company Nebius Group NV NBIS.In a post on X Tuesday, Left recalled his firm's December 2024 thesis, noting it was &#34;Just a pat on the back… from when $NBIS was $20.&#34; The post comes as Nebius stock soars past $90 per share, a massive surge from that price level.Check out NBIS stock price here.<h2>MSFT Deal Worth $17.4 Billion Aids NBIS Surge</h2>The catalyst for the stock’s meteoric rise to $92.50 from $20 per share, when Citron took the position, was a blockbuster deal announced after Monday’s market close. The stock has risen 131.26% on a year-to-date basis.Nebius disclosed a contract with Microsoft Corp. MSFT valued at approximately $17.4 billion to provide dedicated GPU infrastructure capacity through 2031. The news sent Nebius shares skyrocketing more than 44.40% in after-hours trading, pushing its market valuation to levels that have validated early believers like Citron. <h2>From The Next To The Present ‘AI Wall Street Darling’?</h2>Left's celebratory post recalls his take from December 2024, highlighting Citron’s call. At the time, Nebius was trading under $28, and Citron had labeled it the “Next AI Darling,” a “sleeper” stock with no Wall Street analyst coverage despite having Nvidia as an investor. Citron argued then that the market hadn’t “caught on to its massive potential” and was undervalued compared to private competitors like CoreWeave Inc. CRWV, which is now public.<h2>Nebius Gets Significant Leverage After MSFT Deal</h2>The landmark Microsoft deal has cemented Nebius's position in the critical AI supply chain. The move was lauded by market analysts like Shay Boloor of Futurum Equities, who noted that the deal prompted the stock’s addition to the “Futurum AI Fifteen rebalance.”Boloor added that in an environment of “GPU bottlenecks,” the contract gives Nebius significant leverage, locking it “deeper into the AI supply chain right as scarcity defines pricing power.”<h2>Price Action</h2>After a 2.15% decline on Monday, the stock surged 44.40% in after-hours. It was up 144.41% over the last six months and 220.30% over a year.Benzinga’s Edge Stock Rankings indicate that NBIS maintains a stronger price trend in the short, medium, and long terms. However, the stock scores poorly on value rankings. Additional performance details are available here.The SPDR S&amp;P 500 ETF Trust SPY and Invesco QQQ Trust ETF QQQ, which track the S&amp;P 500 index and Nasdaq 100 index, respectively, rose on Monday. The SPY was up 0.25% at $648.83, while the QQQ advanced 0.49% to $578.87, according to Benzinga Pro data.On Tuesday, the futures of the S&amp;P 500, Dow Jones, and Nasdaq 100 indices were trading higher.<ul> <li>Andrew Left’s Citron Research Says Nvidia-Backed Nebius Is The Next ‘AI Wall Street Darling’ — Stock Moves Up 14% </li> </ul>Photo courtesy: Shutterstock</div></div></div>

NBIS

MSFT

Short-seller Andrew Left of Citron Research celebrates a successful bet on Nebius Group NV (NBIS), whose stock has surged over 130% to $92.50 following a $17.4 billion deal with Microsoft for GPU infrastructure. Left recalls his bullish call from December 2024 when NBIS was at $20, labeling it the 'Next AI Darling.' The Microsoft contract has solidified Nebius's position in the AI supply chain, prompting analysts to recognize its potential amidst GPU bottlenecks. Despite a recent decline, NBIS has shown significant gains over the past year, outperforming major indices.

- Andrew Left of Citron Research celebrates a successful bullish call on Nebius Group NV, whose stock surged from $20 to over $90 following a $17.4 billion deal with Microsoft.  
- The contract, which secures dedicated GPU infrastructure through 2031, has significantly boosted Nebius's market position in the AI supply chain, leading to a 131.26% year-to-date increase in stock value.  
- Analysts note that this deal enhances Nebius's leverage amid GPU bottlenecks, validating Citron's early investment thesis that the company was undervalued compared to competitors.

Short Seller Andrew Left Recalls Bet On Nebius As It Soars Over 130% In 2025: 'Just A Pat On The Back' From When NBIS Was At $20 Per Share